Steven Cohen Purple Biotech Ltd. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.15 $648,631 - $1.13 Million	-271,394 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.45 - $4.3 $19,355 - $33,970	-7,900 Reduced 2.83%	271,394 $1.07 Million
Q3 2021 Nov 15, 2021	SELL	$4.4 - $5.59 $1.08 Million - $1.37 Million	-245,706 Reduced 46.8%	279,294 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$3.75 - $6.72 $1.97 Million - $3.53 Million	525,000 New	525,000 $2.56 Million

2.64M

6.6K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $7.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.